Metraipolis › archive › dc_699c096be088

Targeting CXCR2 in prostate cancer cells can block CD47-SIRPα interaction and reverse M2 macrophage polarization in the TME — Europe PMC PMID:41163221

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41163221
DOI
10.1186/s12943-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-08T23:04:22.905Z
SHA-256 of the archived text
74eb34384f4d4f3b7f37d3eb4b5519e410f26964842ab064a672294c14e4a371
Stable URL of this page
https://metraipolis.com/documento/dc_699c096be088

How to cite

Targeting CXCR2 in prostate cancer cells can block CD47-SIRPα interaction and reverse M2 macrophage polarization in the TME — Europe PMC PMID:41163221 — Europe PMC (en), https://europepmc.org/article/MED/41163221 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_699c096be088 (Metraipolis archive dc_699c096be088, sha256 74eb34384f4d4f3b7f37d3eb4b5519e410f26964842ab064a672294c14e4a371)
BibTeX
@misc{dc699c096be088,
  title = {Targeting CXCR2 in prostate cancer cells can block CD47-SIRPα interaction and reverse M2 macrophage polarization in the TME — Europe PMC PMID:41163221},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41163221},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_699c096be088; sha256 74eb34384f4d4f3b7f37d3eb4b5519e410f26964842ab064a672294c14e4a371},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41163221. Agents can read the archived copy with the MCP tool read_document.